NasdaqGS:SNDXBiotechs
Does Syndax Pharmaceuticals’ (SNDX) Russell Value Index Exit Quietly Recast Its Liquidity And Risk Narrative?
On 27 June 2026, Syndax Pharmaceuticals, Inc. was removed from several Russell value benchmarks, including the Russell 2000 Value, 2500 Value, 3000 Value, and 3000E Value indexes.
This broad index removal can meaningfully affect how index-linked investors and benchmark-focused funds treat the stock, potentially altering liquidity and ownership patterns.
Next, we'll examine how Syndax's removal from multiple Russell value benchmarks could influence its existing investment narrative and risk...